La Jolla Pharmaceutical Co
LJPCDelisted Aug 22, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000920465
La Jolla Pharmaceutical Co was delisted on Aug 22, 2022; its insiders filed their last Form 4 on Aug 24, 2022; 41 institutions reported holding it in 13F filings for Q2 2022, worth $53.9M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in La Jolla Pharmaceutical Co as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
LJPC is no longer listed, so this page shows Q2 2022. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 41
- −4 vs. Q1 2022
- Shares held
- 16.9M
- +388.6K (+2.4%) vs. Q1 2022
- Total value
- $53.9M
- −$16.6M (−23.5%) vs. Q1 2022
- New holders
- 2
- 8 more added
- Sold out
- 6
- 17 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LJPC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 41 | $53.9M |
| Q1 2022 | 45 | $70.4M |
| Q4 2021 | 44 | $77.8M |
| Q3 2021 | 54 | $70.9M |
| Q2 2021 | 62 | $78.6M |
| Q1 2021 | 76 | $88.2M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding La Jolla Pharmaceutical Co; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 47 | $0 | 0.00% | −341−87.9% | Reduced |
| Simplex Trading, LLC | 63 | $0 | 0.00% | −267−80.9% | Reduced |
| BNP Paribas Arbitrage, SA | 1 | $3 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 350 | $1.00K | 0.00% | −1,868−84.2% | Reduced |
| Group One Trading, L.P. | 333 | $1.00K | 0.00% | −261−43.9% | Reduced |
| Royal Bank of Canada | 225 | $1.00K | 0.00% | 00.0% | Unchanged |
| Tyler-Stone Wealth Management | 500 | $2.00K | 0.00% | 00.0% | Unchanged |
| SOA Wealth Advisors, LLC. | 1,045 | $3.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,400 | $4.00K | 0.00% | +1,400 | New |
| Tower Research Capital LLC (TRC) | 2,083 | $7.00K | 0.00% | −1,486−41.6% | Reduced |
| Ellis Investment Partners, LLC | 2,800 | $8.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 2,614 | $9.00K | 0.00% | +2+0.1% | Added |
| Meeder Asset Management Inc | 4,159 | $13.0K | 0.00% | −153−3.5% | Reduced |
| Bank of America Corp | 5,407 | $17.0K | 0.00% | −1,185−18.0% | Reduced |
| Barclays PLC | 5,352 | $17.0K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 7,000 | $22.0K | 0.00% | 00.0% | Unchanged |
| Running Point Capital Advisors, LLC | 10,000 | $32.0K | 0.02% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 15,500 | $49.0K | 0.00% | −10,600−40.6% | Reduced |
| Ritholtz Wealth Management | 16,716 | $53.0K | 0.00% | +1,685+11.2% | Added |
| Susquehanna International Group, LLP | 22,193 | $71.0K | 0.00% | +10,647+92.2% | Added |
| WealthTrust Axiom LLC | 25,400 | $81.0K | 0.03% | 00.0% | Unchanged |
| Old National Bancorp | 41,284 | $132.0K | 0.00% | +41,284 | New |
| Morgan Stanley | 43,307 | $138.0K | 0.00% | −758−1.7% | Reduced |
| O'Shaughnessy Asset Management, LLC | 51,017 | $163.0K | 0.00% | +17,385+51.7% | Added |
| Renaissance Technologies LLC | 57,500 | $183.0K | 0.00% | +31,400+120.3% | Added |
| Globeflex Capital L P | 58,611 | $187.0K | 0.05% | −34,188−36.8% | Reduced |
| Hollencrest Capital Management | 80,355 | $256.0K | 0.03% | −2,000−2.4% | Reduced |
| Northern Trust Corp | 80,615 | $257.0K | 0.00% | +562+0.7% | Added |
| FMR LLC | 90,310 | $288.0K | 0.00% | −131−0.1% | Reduced |
| State Street Corp | 98,941 | $316.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 102,606 | $327.0K | 0.00% | −36,283−26.1% | Reduced |
| Bank of New York Mellon Corp | 122,693 | $392.0K | 0.00% | −4,391−3.5% | Reduced |
| Geode Capital Management, LLC | 203,930 | $650.0K | 0.00% | +1,114+0.5% | Added |
| Tang Kevin C | 240,000 | $766.0K | 99.74% | 00.0% | Unchanged |
| BlackRock Inc. | 418,216 | $1.33M | 0.00% | −8,297−1.9% | Reduced |
| Acadian Asset Management LLC | 465,247 | $1.48M | 0.01% | −12,441−2.6% | Reduced |
| D. E. Shaw & Co., Inc. | 581,446 | $1.85M | 0.00% | −18,624−3.1% | Reduced |
| Vanguard Group Inc | 825,481 | $2.63M | 0.00% | 00.0% | Unchanged |
| HealthInvest Partners AB | 1,265,000 | $4.04M | 9.30% | +558,000+78.9% | Added |
| RTW Investments, LP | 2,327,403 | $7.42M | 0.19% | 00.0% | Unchanged |
| Tang Capital Management LLC | 9,607,934 | $30.6M | 4.65% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −50,873−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −34,900−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −27,544−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −13,718−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −13,541−100.0% | Sold out |
| American Portfolios Advisors | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |